{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:52:47Z","timestamp":1787161967878,"version":"build-2736575974"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Black women have a 40% higher breast cancer mortality rate than White women and are at a higher risk of acquiring cardiovascular disease. Proton therapy can be used to mitigate cardiac radiation exposure; however, proton therapy remains a scarce resource in the United States. We report on the cardiovascular profiles of patients undergoing proton therapy to determine the potential benefit of the therapy for Black women compared with patients of other races.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 599 patients with breast cancer who received proton therapy from June 2016 to December 2021 at the Maryland Proton Treatment Center. A variety of sociodemographic, disease, and treatment variables were analyzed using descriptive statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>With a median follow-up of 26\u2009months (range\u2009=\u20090.47-90\u2009months), Black patients made up 31.6% of the population and presented with higher rates of hypertension (P\u2009&amp;lt;\u2009.001), cardiopulmonary conditions (P\u2009&amp;lt;\u2009.001), and a higher median body mass index (P\u2009=\u2009.015) compared with the other cohort, a trend that persisted at the time of post\u2013proton therapy follow-up. Black women had higher rates of triple-negative disease (P\u2009&amp;lt;\u2009.001), with subsequent greater receipt of neoadjuvant chemotherapy (P\u2009=\u2009.039). Pulmonary events were 2.6 times more likely to occur in Black patients than in the non-Black cohort after proton therapy (odds ratio\u2009=\u20092.60, 95% CI\u2009=\u20091.39 to 4.88; P\u2009=\u2009.003).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Black women presenting for proton therapy had higher baseline risks of cardiovascular co-morbidities combined with more aggressive breast cancer biology and a subsequent 2.6-fold increased risk of pulmonary events after proton therapy. Our findings support the use of advanced radiation techniques as a means of sparing important organs at risk, especially in historically marginalized populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jncics\/pkae129","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T15:31:25Z","timestamp":1735227085000},"source":"Crossref","is-referenced-by-count":3,"title":["Cancer outcomes and cardiopulmonary toxicities for Black patients with breast cancer treated with proton therapy"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0979-6048","authenticated-orcid":false,"given":"Gurbani","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-2456","authenticated-orcid":false,"given":"Sravya","family":"Koduri","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, NYU Langone Health , New York, NY 10016,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7193-188X","authenticated-orcid":false,"given":"Manaahil","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meira","family":"Kidorf","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0830-6876","authenticated-orcid":false,"given":"Sarah","family":"Ruff","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshar","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]},{"name":"Department of Radiation Oncology, Chesapeake Oncology-Hematology Associates , Glen Burnie, MD 21061,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-7564","authenticated-orcid":false,"given":"S\u00f8ren M","family":"Bentzen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Biostatistics and Bioinformatics Division, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-3753","authenticated-orcid":false,"given":"Elizabeth","family":"Nichols","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1114-4312","authenticated-orcid":false,"given":"Sarah","family":"McAvoy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-7341","authenticated-orcid":false,"given":"Melissa A L","family":"Vyfhuis","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine , Baltimore, MD 21201,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"2025071409325335100_pkae129-B1","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMp2200244","article-title":"The emergence of the racial disparity in U.S. breast-cancer mortality","volume":"386","author":"Jatoi","year":"2022","journal-title":"N Engl J Med"},{"key":"2025071409325335100_pkae129-B2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2025071409325335100_pkae129-B3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.2158","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2025071409325335100_pkae129-B4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13058-021-01483-y","article-title":"Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women","volume":"23","author":"Barber","year":"2021","journal-title":"Breast Cancer Res"},{"key":"2025071409325335100_pkae129-B5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10549-020-05545-1","article-title":"Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women","volume":"180","author":"Linnenbringer","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"2025071409325335100_pkae129-B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1158\/1055-9965.EPI-17-0945","article-title":"Multilevel examination of health disparity: the role of policy implementation in neighborhood context, in patient resources, and in healthcare facilities on later stage of breast cancer diagnosis","volume":"28","author":"Warnecke","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025071409325335100_pkae129-B7","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"2025071409325335100_pkae129-B8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.118.037689","article-title":"Why are young black women at high risk for cardiovascular disease?","volume":"139","author":"Kalinowski","year":"2019","journal-title":"Circulation"},{"key":"2025071409325335100_pkae129-B9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/s0027-9684(15)30938-x","article-title":"Cardiovascular disease in African American women: a health care disparities issue","volume":"101","author":"Williams","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"2025071409325335100_pkae129-B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11936-020-00869-z","article-title":"Disparities in cardiovascular care and outcomes for women from racial\/ethnic minority backgrounds","volume":"22","author":"Balla","year":"2020","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2025071409325335100_pkae129-B11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"2025071409325335100_pkae129-B12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","article-title":"Radiation therapy-associated toxicity: etiology, management, and prevention","volume":"71","author":"Wang","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025071409325335100_pkae129-B13","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1200\/JCO.2005.05.1037","article-title":"Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment","volume":"24","author":"Harris","year":"2006","journal-title":"J Clin Oncol"},{"key":"2025071409325335100_pkae129-B14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1200\/jco.2011.34.5900","article-title":"Distribution of coronary artery stenosis after radiation for breast cancer","volume":"30","author":"Nilsson","year":"2012","journal-title":"J Clin Oncol"},{"key":"2025071409325335100_pkae129-B15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"2025071409325335100_pkae129-B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12672-023-00636-z","article-title":"Cardiac dose in the treatment of synchronous bilateral breast cancer patients between three different radiotherapy techniques (VMAT, IMRT, and 3D CRT)","volume":"14","author":"Salim","year":"2023","journal-title":"Discov Oncol"},{"key":"2025071409325335100_pkae129-B17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13014-015-0531-4","article-title":"A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT","volume":"10","author":"Zhao","year":"2015","journal-title":"Radiat Oncol"},{"key":"2025071409325335100_pkae129-B18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4048\/jbc.2022.25.e37","article-title":"Intensity modulated radiotherapy and volumetric modulated arc therapy in the treatment of breast cancer: an updated review","volume":"25","author":"Chang","year":"2022","journal-title":"J Breast Cancer"},{"key":"2025071409325335100_pkae129-B19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.14319\/jpt.11.9","article-title":"A treatment planning comparison of volumetric modulated arc therapy and proton therapy for a sample of breast cancer patients treated with post-mastectomy radiotherapy","volume":"1","author":"Hernandez","year":"2015","journal-title":"J Proton Ther"},{"key":"2025071409325335100_pkae129-B20","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1200\/JCO.18.02366","article-title":"Phase II Study of proton beam radiation therapy for patients with breast cancer requiring regional nodal irradiation","volume":"37","author":"Jimenez","year":"2019","journal-title":"J Clin Oncol"},{"key":"2025071409325335100_pkae129-B21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ijrobp.2016.12.008","article-title":"Joint estimation of cardiac toxicity and recurrence risks after comprehensive nodal photon versus proton therapy for breast cancer","volume":"97","author":"Stick","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025071409325335100_pkae129-B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ctrv.2017.11.006","article-title":"Proton therapy for locally advanced breast cancer: a systematic review of the literature","volume":"63","author":"Kammerer","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"2025071409325335100_pkae129-B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025071409325335100_pkae129-B24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.14740\/cr1442","article-title":"Anthracycline-induced cardiotoxicity in breast cancer patients: a five-year retrospective study in 10 centers","volume":"13","author":"Gerodias","year":"2022","journal-title":"Cardiol Res"},{"key":"2025071409325335100_pkae129-B25","doi-asserted-by":"publisher","first-page":"e228970","DOI":"10.1001\/jamanetworkopen.2022.8970","article-title":"Association of race with receipt of proton beam therapy for patients with newly diagnosed cancer in the US, 2004-2018","volume":"5","author":"Nogueira","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025071409325335100_pkae129-B26","doi-asserted-by":"publisher","first-page":"e025556","DOI":"10.1136\/bmjopen-2018-025556","article-title":"Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: The Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol","volume":"9","author":"Bekelman","year":"2019","journal-title":"BMJ Open"},{"key":"2025071409325335100_pkae129-B27","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1002\/cam4.5622","article-title":"\"There\u2019s not enough studies\": Views of black breast and ovarian cancer patients on research participation","volume":"12","author":"Riggan","year":"2023","journal-title":"Cancer Med"},{"key":"2025071409325335100_pkae129-B28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1200\/OP.21.00001","article-title":"Participation of Black Americans in cancer clinical trials: current challenges and proposed solutions","volume":"17","author":"Awidi","year":"2021","journal-title":"J Clin Oncol Oncol Pract"},{"key":"2025071409325335100_pkae129-B29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/cancers13030427","article-title":"Cancer treatment-induced accelerated aging in cancer survivors: biology and assessment","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025071409325335100_pkae129-B30","first-page":"238","article-title":"Hypertension in cancer patients and survivors: epidemiology, diagnosis, and management","volume":"1","author":"Cohen","year":"2019","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"2025071409325335100_pkae129-B31","doi-asserted-by":"crossref","first-page":"100218","DOI":"10.1016\/j.esmoop.2021.100218","article-title":"Increased risk of diabetes in cancer survivors: Aa pooled analysis of 13 population-based cohort studies","volume":"6","author":"Xiao","year":"2021","journal-title":"ESMO Open"},{"key":"2025071409325335100_pkae129-B32","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/cncr.33530","article-title":"Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer","volume":"127","author":"Connor","year":"2021","journal-title":"Cancer"},{"key":"2025071409325335100_pkae129-B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_321315","article-title":"Harnessing nutrition and physical activity for breast cancer prevention and control to reduce racial\/ethnic cancer health disparities","volume":"41","author":"Bandera","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2025071409325335100_pkae129-B34","doi-asserted-by":"publisher","first-page":"100675","DOI":"10.1016\/j.ctro.2023.100675","article-title":"Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT","volume":"43","author":"Ahmadsei","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"2025071409325335100_pkae129-B35","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/j.ijrobp.2023.06.1031","article-title":"Effect of dose to the heart and cardiac substructures on cardiac toxicity after breast cancer radiation","volume":"117","author":"Hogan","year":"2023","journal-title":"Int J Rad OncologyBiologyPhysics"},{"key":"2025071409325335100_pkae129-B36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.radonc.2018.09.021","article-title":"Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy","volume":"132","author":"Tang","year":"2019","journal-title":"Radiother Oncol"},{"key":"2025071409325335100_pkae129-B37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7785\/tcrt.2012.500299","article-title":"Delineation of the cardiac substructures based on PET-CT and contrast-enhanced CT in patients with left breast cancer treated with postoperative radiotherapy","volume":"12","author":"Yu","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"2025071409325335100_pkae129-B38","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1120\/jacmp.v15i5.4624","article-title":"A dosimetry study precisely outlining the heart substructure of left breast cancer patients using intensity-modulated radiation therapy","volume":"15","author":"Fan","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"2025071409325335100_pkae129-B39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijrobp.2014.01.055","article-title":"Dependence of coronary 3-dimensional dose maps on coronary topologies and beam set in breast radiation therapy: a study based on CT angiographies","volume":"89","author":"Moignier","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025071409325335100_pkae129-B40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13014-019-1234-z","article-title":"Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study)","volume":"14","author":"Jacob","year":"2019","journal-title":"Radiat Oncol"},{"key":"2025071409325335100_pkae129-B41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mayocp.2018.07.017","article-title":"Echocardiographic assessment of left ventricular systolic function: an overview of contemporary techniques, including speckle-tracking echocardiography","volume":"94","author":"Luis","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"2025071409325335100_pkae129-B42","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025071409325335100_pkae129-B43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non\u2013small cell lung cancer","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025071409325335100_pkae129-B44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.radonc.2017.01.008","article-title":"A cardiac contouring atlas for radiotherapy","volume":"122","author":"Duane","year":"2017","journal-title":"Radiother Oncol"},{"key":"2025071409325335100_pkae129-B45","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/jnci\/djac120","article-title":"Mediators of racial disparities in heart dose among whole breast radiotherapy patients","volume":"114","author":"Chapman","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"2025071409325335100_pkae129-B46","doi-asserted-by":"publisher","first-page":"13749","DOI":"10.1038\/s41598-021-85401-4","article-title":"Effects of deep inspiration breath hold on prone photon or proton irradiation of breast and regional lymph nodes","volume":"13","author":"Speleers","year":"2023","journal-title":"Sci Rep"},{"key":"2025071409325335100_pkae129-B47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/cncr.25542","article-title":"The association of race\/ethnicity, insurance status, and socioeconomic factors with breast cancer care","volume":"117","author":"Freedman","year":"2011","journal-title":"Cancer"},{"key":"2025071409325335100_pkae129-B48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1001\/jamaoncol.2015.3856","article-title":"Delayed initiation of adjuvant chemotherapy among patients with breast cancer","volume":"2","author":"Chavez-MacGregor","year":"2016","journal-title":"JAMA Oncol"},{"key":"2025071409325335100_pkae129-B49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijrobp.2022.04.003","article-title":"Identifying psychosocial needs of patients with cancer undergoing curative radiation therapy in an inner-city academic center to address racial disparities","volume":"114","author":"Kronfli","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025071409325335100_pkae129-B50","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"2025071409325335100_pkae129-B51","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"2025071409325335100_pkae129-B52","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1016\/j.ijrobp.2021.07.1058","article-title":"Insurance approval for proton therapy in patients with thoracic malignancies: an experience from a cost-neutral payor environment","volume":"111","author":"Mohindra","year":"2021","journal-title":"Int J Rad OncologyBiologyPhysics"},{"key":"2025071409325335100_pkae129-B53","doi-asserted-by":"publisher","first-page":"pky062","DOI":"10.1093\/jncics\/pky062","article-title":"Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review","volume":"2","author":"Caswell-Jin","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"2025071409325335100_pkae129-B54","doi-asserted-by":"publisher","first-page":"4:346","DOI":"10.3389\/fonc.2014.00346","article-title":"Cardiovascular toxicities from systemic breast cancer therapy","volume":"4","author":"Guo","year":"2014","journal-title":"Front Oncol"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkae129\/61290501\/pkae129.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/9\/1\/pkae129\/61290501\/pkae129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/9\/1\/pkae129\/61290501\/pkae129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T13:32:56Z","timestamp":1752499976000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkae129\/7934151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkae129","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,28]]},"article-number":"pkae129"}}